Vertex Pharmaceuticals Inc (VRTX)
489.96
-11.76
(-2.34%)
USD |
NASDAQ |
Nov 12, 16:00
489.96
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Return Level: 501.72 for Nov. 11, 2024
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 11, 2024 | 501.72 |
| November 08, 2024 | 516.74 |
| November 07, 2024 | 502.45 |
| November 06, 2024 | 493.64 |
| November 05, 2024 | 499.88 |
| November 04, 2024 | 472.80 |
| November 01, 2024 | 471.12 |
| October 31, 2024 | 475.98 |
| October 30, 2024 | 475.08 |
| October 29, 2024 | 470.36 |
| October 28, 2024 | 476.37 |
| October 25, 2024 | 477.70 |
| October 24, 2024 | 471.91 |
| October 23, 2024 | 470.05 |
| October 22, 2024 | 474.91 |
| October 21, 2024 | 478.09 |
| October 18, 2024 | 483.00 |
| October 17, 2024 | 498.73 |
| October 16, 2024 | 487.25 |
| October 15, 2024 | 484.30 |
| October 14, 2024 | 484.82 |
| October 11, 2024 | 481.71 |
| October 10, 2024 | 476.15 |
| October 09, 2024 | 467.97 |
| October 08, 2024 | 458.94 |
| Date | Value |
|---|---|
| October 07, 2024 | 448.60 |
| October 04, 2024 | 455.31 |
| October 03, 2024 | 453.55 |
| October 02, 2024 | 462.14 |
| October 01, 2024 | 469.76 |
| September 30, 2024 | 465.08 |
| September 27, 2024 | 462.88 |
| September 26, 2024 | 463.15 |
| September 25, 2024 | 461.76 |
| September 24, 2024 | 462.99 |
| September 23, 2024 | 460.00 |
| September 20, 2024 | 464.92 |
| September 19, 2024 | 477.90 |
| September 18, 2024 | 474.16 |
| September 17, 2024 | 481.26 |
| September 16, 2024 | 489.43 |
| September 13, 2024 | 485.37 |
| September 12, 2024 | 478.65 |
| September 11, 2024 | 474.74 |
| September 10, 2024 | 470.78 |
| September 09, 2024 | 471.11 |
| September 06, 2024 | 468.00 |
| September 05, 2024 | 468.57 |
| September 04, 2024 | 478.57 |
| September 03, 2024 | 475.70 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
177.01
Minimum
Oct 05 2021
516.74
Maximum
Nov 08 2024
297.77
Average
281.36
Median
Aug 30 2022
Total Return Level Benchmarks
| Eli Lilly and Co | 2403.44 |
| Gilead Sciences Inc | 134.74 |
| Bristol-Myers Squibb Co | 245.68 |
| Moderna Inc | 42.75 |
| Sarepta Therapeutics Inc | 117.79 |